Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide with Pre-operative Radiation and/or Chemotherapy in Soft Tissue Sarcoma
NCT00089544Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Jun 2004
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in soft tissue sarcoma (STS), sponsored by National Cancer Institute. Started Jun 2004; status: terminated.
02
Drugs
thalidomide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00089544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089544.